Cambridge Healthtech Institute第3屆

Immuno-Oncology Biomarkers 2: Predictive Biomarkers and Companion Diagnostics

( 癌症免疫療法的生物標記2:預測生物標記與伴隨式診斷 )

2018年8月28日~29日

本單元以對應癌症免疫療法的預測生物標記與伴隨式診斷為主題,製藥公司及研究機關中從事生物標記研究的專家將齊聚一堂,針對癌症免疫療法的預測生物標記及預後生物標記的快速開發、生物標記在臨床試驗的使用、伴隨式診斷的可能性等議題進行討論。

Coverage will include, but is not limited to:

  • Integrative biomarker analysis from immunology, oncology and "omics" data
  • Immune-based biomarkers to predict clinical response
  • Profiling of tumor infiltrating immune cells
  • Microsatellite instability and mismatch repair deficiency biomarkers
  • Biology of tumor microenvironment
  • PD-L1 as a predictive biomarker and companion diagnostic
  • Mechanism of non-response: resistance or lack of efficacy
  • Development of companion diagnostics assays
  • Regulatory considerations in IO biomarker development

* 活動內容有可能不事先告知作更動及調整。

Choose your language
Chinese
Japanese
Korean
English





免費電子郵件通知服務